Literature DB >> 31950013

A case of severe hepatotoxicity induced by cisplatin and 5-fluorouracil.

Ayaka Yaegashi1, Kensuke Yoshida1, Naoto Suzuki1, Izumi Shimada1, Yusuke Tani2, Yasuo Saijo3, Akira Toyama1.   

Abstract

Severe hepatotoxicity from combination chemotherapy with cisplatin and 5-fluorouracil is a rare adverse effect. In this case report, we present a case with severe hepatotoxicity immediately following chemotherapy with cisplatin and 5-fluorouracil. This female patient had previously been treated with this combination with no hepatotoxicity. The elevated liver enzymes quickly normalized after chemotherapy was stopped. There were no specific changes in liver imaging. As hepatotoxicity occurred after repeated administration of cisplatin, we suggest that this hepatotoxicity might represent a case of allergic hepatitis caused by cisplatin. Severe hepatotoxicity should be watched for with repeated administration of cisplatin. © The Japan Society of Clinical Oncology 2019.

Entities:  

Keywords:  5-Fluorouracil; Cisplatin; Hepatotoxicity

Year:  2019        PMID: 31950013      PMCID: PMC6942558          DOI: 10.1007/s13691-019-00394-2

Source DB:  PubMed          Journal:  Int Cancer Conf J        ISSN: 2192-3183


  17 in total

1.  A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907).

Authors:  Nobutoshi Ando; Hoichi Kato; Hiroyasu Igaki; Masayuki Shinoda; Soji Ozawa; Hideaki Shimizu; Tsutomu Nakamura; Hiroshi Yabusaki; Norio Aoyama; Akira Kurita; Kenichiro Ikeda; Tatsuo Kanda; Toshimasa Tsujinaka; Kenichi Nakamura; Haruhiko Fukuda
Journal:  Ann Surg Oncol       Date:  2011-08-31       Impact factor: 5.344

2.  [Combination chemotherapy of cis-diamminedichloroplatinum (CDDP) and 5-fluorouracil (5-FU) in gastrointestinal tumors].

Authors:  H Yamazaki; M Ogawa; N Horikoshi; K Inoue; T Nakamura; K Ueno; Y Ito; K Imajo; T Mukaiyama; K Miyaoka
Journal:  Gan To Kagaku Ryoho       Date:  1986-08

3.  Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer.

Authors:  P H Sugarbaker; F J Gianola; J C Speyer; R Wesley; I Barofsky; C E Meyers
Journal:  Surgery       Date:  1985-09       Impact factor: 3.982

4.  Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review.

Authors:  Nektaria Makrilia; Ekaterini Syrigou; Ioannis Kaklamanos; Leonidas Manolopoulos; Muhammad Wasif Saif
Journal:  Met Based Drugs       Date:  2010-09-20

Review 5.  [Hypersensitivity reactions to cancer chemotherapeutic agents].

Authors:  Atsushi Sato; Akiko Sakashita; Susumu Taguchi
Journal:  Gan To Kagaku Ryoho       Date:  2003-06

6.  Discontinuation of nevirapine because of hypersensitivity reactions in patients with prior treatment experience, compared with treatment-naive patients: the ATHENA cohort study.

Authors:  Ferdinand W N M Wit; Anouk M Kesselring; Luuk Gras; Clemens Richter; Marchina E van der Ende; Kees Brinkman; Joep M A Lange; Frank de Wolf; Peter Reiss
Journal:  Clin Infect Dis       Date:  2008-03-15       Impact factor: 9.079

Review 7.  Toxicity of platinum compounds.

Authors:  Jörg Thomas Hartmann; Hans-Peter Lipp
Journal:  Expert Opin Pharmacother       Date:  2003-06       Impact factor: 3.889

8.  Lethal hepatotoxicity following 5-fluorouracil/cisplatin chemotherapy: a relevant case report.

Authors:  Aline Hajj; Marwan Ghosn; Diane Mourad; Khalil Hojaiban; Perla Mousallem; Lydia Rabbaa Khabbaz
Journal:  Per Med       Date:  2017-05-05       Impact factor: 2.512

9.  Comparison between neoadjuvant chemotherapy followed by surgery and definitive chemoradiotherapy for overall survival in patients with clinical Stage II/III esophageal squamous cell carcinoma (JCOG1406-A).

Authors:  Motoo Nomura; Ken Kato; Nobutoshi Ando; Atsushi Ohtsu; Kei Muro; Hiroyasu Igaki; Tetsuya Abe; Hiroya Takeuchi; Hiroyuki Daiko; Masahiro Gotoh; Kozo Kataoka; Masashi Wakabayashi; Yuko Kitagawa
Journal:  Jpn J Clin Oncol       Date:  2017-06-01       Impact factor: 3.019

Review 10.  Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy: A case series and review of the literature.

Authors:  Seiichiro Mitani; Shigenori Kadowaki; Azusa Komori; Keiji Sugiyama; Yukiya Narita; Hiroya Taniguchi; Takashi Ura; Masashi Ando; Yozo Sato; Hidekazu Yamaura; Yoshitaka Inaba; Makoto Ishihara; Tsutomu Tanaka; Masahiro Tajika; Kei Muro
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

View more
  3 in total

Review 1.  Pro-Inflammatory Signalling PRRopels Cisplatin-Induced Toxicity.

Authors:  Ivan K Domingo; Asna Latif; Amit P Bhavsar
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

2.  Alleviation of cisplatin-induced hepatotoxicity by gliclazide: Involvement of oxidative stress and caspase-3 activity.

Authors:  Fatemeh Taghizadeh; Seyed Jalal Hosseinimehr; Mehryar Zargari; Abbasali Karimpour Malekshah; Mansoureh Mirzaei; Fereshteh Talebpour Amiri
Journal:  Pharmacol Res Perspect       Date:  2021-05

3.  Rationale for Tailoring an Alternative Oncology Trial Using a Novel Gallium-Based Nanocomplex: Mechanistic Insights and Preclinical Challenges.

Authors:  Nihal Mostafa; Ahmed Salem; Somaya Z Mansour; Sawsan M El-Sonbaty; Fatma S M Moawed; Eman I Kandil
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.